Wednesday, 26 March 2014

Verastem to present data on product candidates targeting cancer stem cells

Logo of verastem
Verastem, a company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced today that it will present data at the upcoming American Association of Cancer Research (AACR) meeting to be held April 5-9, 2014 at the San Diego Convention Center in San Diego, CA.
“The four presentations at the upcoming AACR meeting demonstrate our commitment to furthering the body of knowledge surrounding the role of cancer stem cells as the driving factor in tumor progression. he data in these presentations support our growing pipeline of clinical product candidates and provide insight into our clinical development in a number of different cancers. We will present data generated in experiments with our cancer stem cell targeting agents that act through inhibition of the FAK and PI3K/mTOR pathways, including our lead candidate VS-6063, currently in the registration-directed COMMAND study for the treatment of mesothelioma.” said Jonathan Pachter, Ph.D., Verastem Head of Research.

To read the presentation details please click here


No comments:

Post a Comment

Please note that we dont offer any kind of medical advice. Questions requesting specific medical advice (e.g. where can I get this treatment, will this cure XXX condition, etc) will be published but most probably ignored by the administrators. :)

Note to spammers: You shall not pass. If you really want a link from us then consider making a stem cell related guest post !